| Medical and Health Sciences | Lifetime | 197 | US 108 | 99.99 |
| Medical and Health Sciences | 2021-2025 | 3 | US 2 | 100.00 |
| Epidemiology | Lifetime | 8 | US 6 | 99.99 |
| Hepatology | Lifetime | 51 | US 24 | 99.67 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 504 | US 273 | 98.46 |
| Pathology and Forensic Medicine | Lifetime | 937 | US 422 | 95.29 |
| Epidemiology | 2021-2025 | 1 | US 1 | 100.00 |
| Hepatology | 2021-2025 | 3 | US 2 | 99.88 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 49 | US 31 | 99.42 |
| Pathology and Forensic Medicine | 2021-2025 | 99 | US 38 | 97.78 |
| Surgery | 2021-2025 | 516 | US 198 | 95.80 |
| Molecular Biology | 2021-2025 | 893 | US 250 | 95.02 |
| Medical Physiology | 2021-2025 | 639 | US 237 | 90.18 |
| Liver Disease Diagnosis and Treatment | Lifetime | 2 | US 2 | 99.98 |
| Diet, Metabolism, and Disease | Lifetime | 3 | US 3 | 99.95 |
| Liver Diseases and Immunity | Lifetime | 2 | US 1 | 99.94 |
| Liver Disease and Transplantation | Lifetime | 8 | US 4 | 99.94 |
| Pancreatitis Pathology and Treatment | Lifetime | 26 | US 13 | 99.77 |
| Alcohol Consumption and Health Effects | Lifetime | 19 | US 15 | 99.62 |
| Hepatocellular Carcinoma Treatment and Prognosis | Lifetime | 40 | US 19 | 99.77 |
| Hepatitis C virus research | Lifetime | 86 | US 32 | 99.68 |
| Hepatitis B Virus Studies | Lifetime | 210 | US 75 | 99.33 |
| Diet and metabolism studies | Lifetime | 631 | US 275 | 98.89 |
| Gut microbiota and health | Lifetime | 506 | US 173 | 98.32 |
| Endoplasmic Reticulum Stress and Disease | Lifetime | 284 | US 150 | 97.95 |
| Congenital Heart Disease Studies | Lifetime | 540 | US 304 | 98.01 |
| Fibroblast Growth Factor Research | Lifetime | 181 | US 91 | 96.92 |
| Folate and B Vitamins Research | Lifetime | 508 | US 248 | 96.40 |
| Cardiovascular Disease and Adiposity | Lifetime | 746 | US 355 | 96.51 |
| Lipid metabolism and disorders | Lifetime | 583 | US 221 | 94.30 |
| Coronary Artery Anomalies | Lifetime | 850 | US 392 | 93.32 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 1 | US 1 | 100.00 |
| Pancreatitis Pathology and Treatment | 2021-2025 | 1 | US 1 | 99.96 |
| Liver Disease and Transplantation | 2021-2025 | 2 | US 2 | 99.98 |
| Diet, Metabolism, and Disease | 2021-2025 | 1 | US 1 | 99.99 |
| Liver Diseases and Immunity | 2021-2025 | 1 | US 1 | 99.99 |
| Alcohol Consumption and Health Effects | 2021-2025 | 2 | US 2 | 99.82 |
| Hepatitis C virus research | 2021-2025 | 5 | US 1 | 99.82 |
| Hepatocellular Carcinoma Treatment and Prognosis | 2021-2025 | 16 | US 7 | 99.69 |
| Endoplasmic Reticulum Stress and Disease | 2021-2025 | 5 | US 2 | 99.18 |
| Diet and metabolism studies | 2021-2025 | 79 | US 23 | 98.88 |
| Folate and B Vitamins Research | 2021-2025 | 11 | US 1 | 95.46 |
| Hepatitis B Virus Studies | 2021-2025 | 67 | US 11 | 98.22 |
| Fibroblast Growth Factor Research | 2021-2025 | 15 | US 9 | 97.69 |
| Lipid metabolism and disorders | 2021-2025 | 18 | US 8 | 97.02 |
| Drug-Induced Hepatotoxicity and Protection | 2021-2025 | 475 | US 70 | 80.56 |
| Kruppel-like factors research | 2021-2025 | 255 | US 64 | 73.56 |
| Peroxisome Proliferator-Activated Receptors | 2021-2025 | 553 | US 99 | 67.82 |